Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2308 to 2357 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2308\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase pkx1 (ec 2.7.1.-). [source:swissprot;acc:p51817]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.543\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.459\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00505\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2309\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase, gamma-catalytic subunit (ec 2.7.1.37) (pka c-gamma). [source:swissprot;acc:p22612]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.542\vspace{3pt}}&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2310\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin. [source:swissprot;acc:p02248]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.617\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.529\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2311\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase, beta-catalytic subunit (ec 2.7.1.37) (pka c-beta). [source:swissprot;acc:p22694]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
215.542\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.459\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2312\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase, alpha-catalytic subunit (ec 2.7.1.37) (pka c-alpha). [source:swissprot;acc:p17612]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2313\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase type ii-beta regulatory chain. [source:swissprot;acc:p31323]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.529\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.449\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00504\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2314\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2-17 kda 2 (ec 6.3.2.19) (ubiquitin- protein ligase) (ubiquitin carrier protein) (e2(17)kb 2). [source:swissprot;acc:p51669]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
194.743\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
195.708\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00496\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2315\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acetyl-coa carboxylase 2 (ec 6.4.1.2) (acc-beta) [includes: biotin carboxylase (ec 6.3.4.14)]. [source:swissprot;acc:o00763]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
194.825\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
195.787\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00494\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2316\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 12 (26s proteasome regulatory subunit p55). [source:swissprot;acc:o00232]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.241\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.311\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00493\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2317\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 6 (ec 3.1.3.16) (pp6). [source:swissprot;acc:o00743]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
194.834\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
195.794\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2318\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sporulation-induced transcript 4-associated protein. [source:refseq;acc:nm\_018312]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2319\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acetyl-coa carboxylase 1 (ec 6.4.1.2) (acc-alpha) [includes: biotin carboxylase (ec 6.3.4.14)]. [source:swissprot;acc:q13085]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
194.842\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
195.8\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00492\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2320\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rad54-like protein; rad54 homolog. [source:refseq;acc:nm\_003579]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.292\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.218\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2321\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tetratricopeptide repeat protein 4 (my044 protein). [source:swissprot;acc:o95801]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
203.909\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.925\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00485\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2322\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
trans-prenyltransferase; polyprenyl pyrophosphate synthetase. [source:refseq;acc:nm\_014317]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
236.023\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
234.905\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00476\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2323\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
asparaginyl-trna synthetase, cytoplasmic (ec 6.1.1.22) (asparagine-- trna ligase) (asnrs). [source:swissprot;acc:o43776]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
192.773\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.691\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2324\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 1 (ec 3.4.25.1) (proteasome component c5) (macropain subunit c5) (multicatalytic endopeptidase complex subunit c5) (proteasome gamma chain). [source:swissprot;acc:p20618]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.129\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.129\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00474\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2325\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
methionyl-trna formyltransferase, mitochondrial precursor (ec 2.1.2.9) (mtfmt). [source:swissprot;acc:q96dp5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.728\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.685\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00473\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2326\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 4 (ec 2.7.1.-) (map kinase kinase 4) (jnk activating kinase 1) (c-jun n- terminal kinase kinase 1) (jnkk) (sapk/erk kinase 1) (sek1). [source:swissprot;acc:p45985]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.076\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00468\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2327\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s protease regulatory subunit 6b (mip224) (mb67 interacting protein) (tat-binding protein-7) (tbp-7). [source:swissprot;acc:p43686]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.413\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.426\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00466\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2328\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
xpmc2 prevents mitotic catastrophe 2 homolog; xenopus prevents mitotic catastrophe 2 homolog. [source:refseq;acc:nm\_020385]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.326\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.357\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00465\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2329\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 13 (26s proteasome regulatory subunit s11) (26s proteasome regulatory subunit p40.5). [source:swissprot;acc:q9unm6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.112\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.116\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00462\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2330\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phenylalanyl-trna synthetase beta chain (ec 6.1.1.20) (phenylalanine-- trna ligase beta chain) (phers) (hspc173). [source:swissprot;acc:q9nsd9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.213\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.235\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00459\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2331\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mbd2 (methyl-cpg-binding protein)-interacting zinc finger protein. [source:refseq;acc:nm\_015517]\vspace{3pt}}&\multirow{12}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
229.258\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
230.294\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00452\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2332\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
skeletal muscle tropomodulin (sk-tmod) (tropomodulin 4). [source:swissprot;acc:q9nzq9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2333\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitous tropomodulin (u-tmod) (tropomodulin 3). [source:swissprot;acc:q9nyl9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2334\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tropomodulin 1 (erythrocyte tropomodulin) (e-tmod). [source:swissprot;acc:p28289]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2335\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 9 (sh3 and px domain-containing protein 1) (sdp1 protein). [source:swissprot;acc:q9y5x1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2336\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal tropomodulin (n-tmod) (tropomodulin 2). [source:swissprot;acc:q9nzr1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2337\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein dlx-2. [source:swissprot;acc:q07687]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2338\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein dlx-5. [source:swissprot;acc:p56178]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2339\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fetal brain protein 239 (239fb). [source:swissprot;acc:q15777]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2340\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein dlx-3. [source:swissprot;acc:o60479]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2341\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
activated p21cdc42hs kinase. [source:refseq;acc:nm\_005781]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2342\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 7 interacting protein 2 isoform 1; tak1-binding protein 2. [source:refseq;acc:nm\_015093]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2343\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycine cleavage system h protein, mitochondrial precursor. [source:swissprot;acc:p23434]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.222\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00451\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2344\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kccr13l. [source:refseq;acc:nm\_139179]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
219.878\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.893\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0045\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2345\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna repair protein rad51 homolog 1 (hrad51) (hsrad51). [source:swissprot;acc:q06609]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2346\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek1 (ec 2.7.1.37) (nima-related protein kinase 1) (ny-ren-55 antigen). [source:swissprot;acc:q96py6]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.057\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.03\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00448\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2347\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek3 (ec 2.7.1.37) (nima-related protein kinase 3) (hspk 36). [source:swissprot;acc:p51956]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2348\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glyceraldehyde 3-phosphate dehydrogenase, liver (ec 1.2.1.12) (gapdh). [source:swissprot;acc:p04406]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2349\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fibulin-1 precursor. [source:swissprot;acc:p23142]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
192.348\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.503\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00441\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2350\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytosolic nonspecific dipeptidase (glutamate carboxypeptidase-like protein 1). [source:swissprot;acc:q96kp4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.811\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.733\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00439\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2351\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synaptotagmin xii (sytxii). [source:swissprot;acc:q8iv01]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.223\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.289\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00438\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2352\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
copper-transporting atpase 1 (ec 3.6.3.4) (copper pump 1) (menkes disease-associated protein). [source:swissprot;acc:q04656]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.088\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.155\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00436\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2353\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
electron transfer flavoprotein beta-subunit (beta-etf). [source:swissprot;acc:p38117]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
182.232\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
183.027\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2354\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
copper-transporting atpase 2 (ec 3.6.3.4) (copper pump 2) (wilson disease-associated protein). [source:swissprot;acc:p35670]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.078\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.148\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00434\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2355\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 7 (26s proteasome regulatory subunit s12) (proteasome subunit p40) (mov34 protein homolog). [source:swissprot;acc:p51665]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.232\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.162\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00428\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2356\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin 4. [source:refseq;acc:nm\_024658]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.921\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.863\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00426\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2357\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 g2 (ec 6.3.2.19) (ubiquitin-protein ligase g2) (ubiquitin carrier protein g2). [source:swissprot;acc:p56554]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.181\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
197.346\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00423\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/